Thin layer chromatography was performed on Merck 60F 254 sheets with detection by UV and by charring with 5% ethanolic H 2 SO 4 . Unless otherwise stated, TLC was eluted with ethyl acetate / isopropanol / water 3:2:1. Hygroscopic reagents were dried in vacuo immediately prior to weighing. NMR spectra were taken on Bruker DPX 250, AM 300, AV 360 or DRX 400 spectrometers, using the residual protonated solvent as internal standard. Chemical shifts ! are given in parts per million (ppm). Mass spectra were taken on a ThermoFinnigan Mat 95, with Electrospray ionization in the positive (ESI +
MS (ESI +
)
hydroxymethyl-1-("-D-glucopyranosyl)-1H-[1,2,3]-triazole

3.62-3.45 (m, 3H, H-3', H-4', H-5')
. 13 C NMR (75 MHz, methanol-d4) !: 149.1 (C-4); 123.4
(C-5); 89.5 (C-1'); 81.1 (C-5'); 78.5 (C-3'); 74.0 (C-2'); 70.9 (C-4'); 62.4 (C-6'); 59. 31.2 mg per ml of H 2 O, 3.1 mg, 12.5 µmol, 5 mol%). The reaction mixture was stirred at room temperature for 2 hours, and activated charcoal was added followed by 45 min of stirring under an air atmosphere. Purification by filtration and evaporation gave 62.5 mg Following µmol, 1 eq.), o-phenylenediamine (220 µl, 40.5 mg per ml of H 2 O, 8.9 mg, 82.5 µmol, 15 mol%), sodium ascorbate (220 µl, 49.5 mg per ml of H 2 O, 10.9 mg, 55.5 µmol, 10 mol%) and copper sulfate pentahydrate (220 µl, 31.2 mg per ml of H 2 O, 6.9 mg, 27.5 µmol, 5 mol%).
The reaction mixture was stirred at room temperature for 45 min, and activated charcoal was added followed by overnight stirring under an air atmosphere. Purification by filtration and To a solution of #-D-glucopyranosyl azide (64. 4.00 (dd, 1H, J 2",1" 9.0, J 2",3" 9.0 Hz, H-2"); 3.91 (dd, 1H, J 6a",6b" 12.0, J 6a",5" 2.0 Hz, H-6a");
mg (89%) of 4-(1'-methyl-1H-imidazol-5'-yl)-1-("-Dglucopyranosyl)-1H-[1,2,3]-triazole
3.84 (s, 3H, NCH 3 ); 3.7 (dd, 1H, J 6a",6b" 12.0, J 6b",5" 5.0 Hz, H-6b"); 3.68 (ddd, 1H, J 5",4" 9.5, J 5",6b" 5.0, J 5",6a" 2.0 Hz, H-5"); 3.67 (dd, 1H, J 3",4" 9.0, J 3",2" 9.0 Hz, H-3"); 3.59 (dd, 1H, J 4",3" 9.0, J 4",5" 9.5 Hz, H-4"). 13 
Following Procedure B, 4-(1'-hydroxycyclohexyl)-1-("-D-glucopyranosyl)-1H-[1,2,3]-triazole
